Kibbe MR - Search Results

1

Development of novel nanofibers targeted to smoke-injured lungs.

Mercel AI, Marulanda K, Gillis DC, Sun K, Clemons TD, Willcox S, Griffith J, Peters EB, Karver MR, Tsihlis ND, Maile R, Stupp SI, Kibbe MR. Mercel AI, et al. Among authors: kibbe mr. Biomaterials. 2021 Jul;274:120862. doi: 10.1016/j.biomaterials.2021.120862. Epub 2021 Apr 29. Biomaterials. 2021. PMID: 33975274 Free PMC article.

2

The role of nitric oxide in the pathophysiology of intimal hyperplasia.

Ahanchi SS, Tsihlis ND, Kibbe MR. Ahanchi SS, et al. Among authors: kibbe mr. J Vasc Surg. 2007 Jun;45 Suppl A:A64-73. doi: 10.1016/j.jvs.2007.02.027. J Vasc Surg. 2007. PMID: 17544026 Free article. Review.

3

Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia.

Kapadia MR, Chow LW, Tsihlis ND, Ahanchi SS, Eng JW, Murar J, Martinez J, Popowich DA, Jiang Q, Hrabie JA, Saavedra JE, Keefer LK, Hulvat JF, Stupp SI, Kibbe MR. Kapadia MR, et al. Among authors: kibbe mr. J Vasc Surg. 2008 Jan;47(1):173-82. doi: 10.1016/j.jvs.2007.09.005. J Vasc Surg. 2008. PMID: 18178471 Free PMC article.

4

Basic science review: nitric oxide--releasing prosthetic materials.

Varu VN, Tsihlis ND, Kibbe MR. Varu VN, et al. Among authors: kibbe mr. Vasc Endovascular Surg. 2009 Apr-May;43(2):121-31. doi: 10.1177/1538574408322752. Epub 2008 Sep 17. Vasc Endovascular Surg. 2009. PMID: 18799500 Review.

5

Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome.

Ahanchi SS, Varu VN, Tsihlis ND, Martinez J, Pearce CG, Kapadia MR, Jiang Q, Saavedra JE, Keefer LK, Hrabie JA, Kibbe MR. Ahanchi SS, et al. Among authors: kibbe mr. Am J Physiol Heart Circ Physiol. 2008 Dec;295(6):H2388-98. doi: 10.1152/ajpheart.00185.2008. Epub 2008 Oct 17. Am J Physiol Heart Circ Physiol. 2008. PMID: 18931034 Free PMC article.

6

Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injury.

Tsihlis ND, Murar J, Kapadia MR, Ahanchi SS, Oustwani CS, Saavedra JE, Keefer LK, Kibbe MR. Tsihlis ND, et al. Among authors: kibbe mr. J Vasc Surg. 2010 May;51(5):1248-59. doi: 10.1016/j.jvs.2009.12.028. Epub 2010 Mar 11. J Vasc Surg. 2010. PMID: 20223627 Free PMC article.

7

Nitric oxide inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by increasing the ubiquitination and degradation of UbcH10.

Tsihlis ND, Oustwani CS, Vavra AK, Jiang Q, Keefer LK, Kibbe MR. Tsihlis ND, et al. Among authors: kibbe mr. Cell Biochem Biophys. 2011 Jun;60(1-2):89-97. doi: 10.1007/s12013-011-9179-3. Cell Biochem Biophys. 2011. PMID: 21448667 Free PMC article.

8

Nitric oxide increases lysine 48-linked ubiquitination following arterial injury.

Oustwani CS, Tsihlis ND, Vavra AK, Jiang Q, Martinez J, Kibbe MR. Oustwani CS, et al. Among authors: kibbe mr. J Surg Res. 2011 Sep;170(1):e169-77. doi: 10.1016/j.jss.2011.05.032. Epub 2011 Jun 15. J Surg Res. 2011. PMID: 21737094 Free PMC article.

9

Nitric oxide decreases activity and levels of the 11S proteasome activator PA28 in the vasculature.

Tsihlis ND, Kapadia MR, Vavra AK, Jiang Q, Fu B, Martinez J, Kibbe MR. Tsihlis ND, et al. Among authors: kibbe mr. Nitric Oxide. 2012 Jun 30;27(1):50-8. doi: 10.1016/j.niox.2012.04.006. Epub 2012 Apr 24. Nitric Oxide. 2012. PMID: 22561112

10

Nitric oxide delivery via a permeable balloon catheter inhibits neointimal growth after arterial injury.

Havelka GE, Moreira ES, Rodriguez MP, Tsihlis ND, Wang Z, Martínez J, Hrabie JA, Kiefer LK, Kibbe MR. Havelka GE, et al. Among authors: kibbe mr. J Surg Res. 2013 Mar;180(1):35-42. doi: 10.1016/j.jss.2012.10.048. Epub 2012 Nov 10. J Surg Res. 2013. PMID: 23164361 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

352 results

Search Page